Epigenome-wide scan identifies differentially methylated regions for lung cancer using pre-diagnostic peripheral blood

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   Google Scholar
• Va M. Force USPST. Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2014;160(5):330–338.
   Google Scholar
• National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.
   Google Scholar
• Fabrikant MS, Wisnivesky JP, Marron T, et al. Benefits and challenges of lung cancer screening in older adults. Clin Ther. 2018;40:526–534.
   Google Scholar
• Heleno B, Siersma V, Brodersen J. Estimation of overdiagnosis of lung cancer in low-dose computed tomography screening: a secondary analysis of the Danish lung cancer screening trial. JAMA Intern Med. 2018;178(10):1420–1422.
   Google Scholar
• Patz EF Jr., Pinsky P, Gatsonis C, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174(2):269–274.
   Google Scholar
• McCunney RJ, Li J. Radiation risks in lung cancer screening programs. Chest. 2014;145(3):618–624.
   Google Scholar
• Quaife SL, Ruparel M, Beeken RJ, et al. The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’patients. BMC Cancer. 2016;16(1):1–9.
   Google Scholar
• Shenker NS, Polidoro S, Van Veldhoven K, et al. Epigenome-wide association study in the European prospective investigation into cancer and nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet. 2013;22(5):843–851.
   Google Scholar
• Baglietto L, Ponzi E, Haycock P, et al. DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk. Int J Cancer. 2017;140(1):50–61.
   Google Scholar
• Ligthart S, Marzi C, Aslibekyan S, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17(1):255.
   Google Scholar
• Ahsan M, Ek WE, Rask-Andersen M, et al. The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseases. PLoS Genet. 2017;13(9):e1007005.
   Google Scholar
• Wahl S, Drong A, Lehne B, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2016;541:81.
   Google Scholar
• Xu K, Zhang X, Wang Z, et al. Epigenome-wide association analysis revealed that SOCS3 methylation influences the effect of cumulative stress on obesity. Biol Psychol. 2018;131:63–71.
   Google Scholar
• Chambers JC, Loh M, Lehne B, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015;3(7):526–534.
   Google Scholar
• Huan T, Joehanes R, Song C, et al. Genome-wide identification of DNA methylation QTLs in whole blood highlights pathways for cardiovascular disease. Nat Commun. 2019;10(1):4267.
   Google Scholar
• Agha G, Mendelson MM, Ward-Caviness CK, et al. Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease. Circulation. 2019;140(8):645–657.
   Google Scholar
• Zhang Y, Elgizouli M, Schottker B, et al. Smoking-associated DNA methylation markers predict lung cancer incidence. Clin Epigenetics. 2016;8:127.
   Google Scholar
• Zhang Y, Breitling LP, Balavarca Y, et al. Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer-related genes in prediction of lung cancer mortality. Int J Cancer. 2016;139(11):2482–2492.
   Google Scholar
• Fasanelli F, Baglietto L, Ponzi E, et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun. 2015;6(1):1–9.
   Google Scholar
• Joehanes R, Just AC, Marioni RE, et al. Epigenetic signatures of cigarette smoking. Circulation. 2016;9(5):436–447.
   Google Scholar
• Sandanger TM, Nøst TH, Guida F, et al. DNA methylation and associated gene expression in blood prior to lung cancer diagnosis in the Norwegian Women and Cancer cohort. Sci Rep. 2018;8(1):1–10.
   Google Scholar
• Battram T, Richmond RC, Baglietto L, et al. Appraising the causal relevance of DNA methylation for risk of lung cancer. Int J Epidemiol. 2019;48(5):1493–1504.
   Google Scholar
• Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166(6):646–655.
   Google Scholar
• Munafò MR, Timofeeva MN, Morris RW, et al. Association between genetic variants on chromosome 15q25 locus and objective measures of tobacco exposure. J Natl Cancer Inst. 2012;104(10):740–748.
   Google Scholar
• Zhang X, Gao L, Liu Z-P, et al. Uncovering driver DNA methylation events in nonsmoking early stage lung adenocarcinoma. BioMed Research International. 2016;2016:2090286. doi:https://doi.org/10.1155/2016/2090286.
   Google Scholar
• Genkinger JM, Platz EA, Hoffman SC, et al. Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol. 2004;160(12):1223–1233.
   Google Scholar
• Kakourou A, Koutsioumpa C, Lopez DS, et al. Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies. Cancer Causes Control. 2015;26(10):1449–1460.
   Google Scholar
• Schober SE, Comstock GW, Helsing KJ, et al. Serologic precursors of cancer: i. Prediagnostic serum nutrients and colon cancer risk. Am J Epidemiol. 1987;126(6):1033–1041.
   Google Scholar
• Comstock GW, Helzlsouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr. 1991;53(1Suppl):260S–264S.
   Google Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883.
   Google Scholar
• Leek JT, Scharpf RB, Bravo HC, et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet. 2010;11(10):733–739.
   Google Scholar
• Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.
   Google Scholar
• Salas LA, Koestler DC, Butler RA, et al. An optimized library for reference-based deconvolution of whole-blood biospecimens assayed using the Illumina HumanMethylationEPIC BeadArray. Genome Biol. 2018;19(1):64.
   Google Scholar
• Adalsteinsson BT, Gudnason H, Aspelund T, et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One. 2012;7(10):e46705.
   Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal statistical society: series B (Methodological). 1995;57(1):289–300.
   Google Scholar
• Peters TJ, Buckley MJ, Statham AL, et al. De novo identification of differentially methylated regions in the human genome. Epigenetics Chromatin. 2015;8:6.
   Google Scholar
• Wang L, Aakre JA, Jiang R, et al. Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J Thorac Oncol. 2010;5(6):778–785.
   Google Scholar
• Leng S, Wu G, Klinge DM, et al. Gene methylation biomarkers in sputum as a classifier for lung cancer risk. Oncotarget. 2017;8(38):63978.
   Google Scholar
• Liu D, Peng H, Sun Q, et al. The indirect efficacy comparison of DNA methylation in sputum for early screening and auxiliary detection of lung cancer: a meta-analysis. Int J Environ Res Public Health. 2017;14(7):679.
   Google Scholar
• Sato K, Tomizawa Y, Iijima H, et al. Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep. 2005;15(1):129–135.
   Google Scholar
• Huang Z, Lei W, Hu HB, et al. H19 promotes non‐small‐cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR‐17. J Cell Physiol. 2018;233(10):6768–6776.
   Google Scholar
• Liu J, Shangguan Y, Sun J, et al. BAIAP2L2 promotes the progression of gastric cancer via AKT/mTOR and Wnt3a/β-catenin signaling pathways. Biomed Pharmacother. 2020;129:110414.
   Google Scholar
• Chen P, Zuo H, Xiong H, et al. Gpr132 sensing of lactate mediates tumor–macrophage interplay to promote breast cancer metastasis. Proc Nat Acad Sci. 2017;114(3):580–585.
   Google Scholar
• Lopes R, Korkmaz G, Revilla SA, et al. CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells. Cancer Lett. 2018;436:87–95.
   Google Scholar
• Guo X, Lin W, Bao J, et al. A comprehensive cis-eQTL analysis revealed target genes in breast cancer susceptibility loci identified in genome-wide association studies. Am J Hum Genet. 2018;102(5):890–903.
   Google Scholar
• Gao Q-Z, Qin Y, Wang W-J, et al. Overexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway. World J Clin Cases. 2020;8(15):3197.
   Google Scholar
• Sieuwerts AM, Meijer-van Gelder ME, Timmermans M, et al. How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study. Clin Cancer Res. 2005;11(20):7311–7321.
   Google Scholar
• He Y, Ji P, Li Y, et al. Genetic variants were associated with the prognosis of head and neck squamous Carcinoma. Front Oncol. 2020;10:372.
   Google Scholar
• Yanagawa N, Tamura G, Oizumi H, et al. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer. 2007;58(1):131–138.
   Google Scholar
• Xu K, Liu B, Ma Y. The tumor suppressive roles of ARHGAP25 in lung cancer cells. Onco Targets Ther. 2019;12:6699.
   Google Scholar
• Liu H, Zhao H. Prognosis related miRNAs, DNA methylation, and epigenetic interactions in lung adenocarcinoma. Neoplasma. 2019;66(3):487–493.
   Google Scholar
• Zhu Z, Wang H, Wei Y, et al. Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis. Tumor Biol. 2017;39(4):1010428317695929.
   Google Scholar
• Ying X, Zhu J, Circular ZY. RNA circ‐TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR‐665. Mol Genet Genomic Med. 2019;7(12):e991.
   Google Scholar
• A-j X, X-h X, S-t D, et al. Clinical significance of PHPT1 protein expression in lung cancer. Chin Med J (Engl). 2010;123(22):3247–3251.
   Google Scholar
• Kudinov AE, Deneka A, Nikonova AS, et al. Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Nat Acad Sci. 2016;113(25):6955–6960.
   Google Scholar
• Yu Y-H, Chiou G-Y, Huang P-I, et al. Network biology of tumor stem-like cells identified a regulatory role of CBX5 in lung cancer. Sci Rep. 2012;2:584.
   Google Scholar
• Ma N, Shen W, Pang H, et al. The effect of RCAN1 on the biological behaviors of small cell lung cancer. Tumor Biol. 2017;39(6):1010428317700405.
   Google Scholar
• Huang C-Y, Fong Y-C, Lee C-Y, et al. CCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathways. Biochem Pharmacol. 2009;77(5):794–803.
   Google Scholar
• Grunwald C, Koslowski M, Arsiray T, et al. Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. Int J Cancer. 2006;118(10):2522–2528.
   Google Scholar
• Nass N, Walter S, Jechorek D, et al. High neuronatin (NNAT) expression is associated with poor outcome in breast cancer. Virchows Arch. 2017;471(1):23–30.
   Google Scholar
• Zhu Y, Lin H, Li Z, et al. Modulation of expression of ribosomal protein L7a (rpL7a) by ethanol in human breast cancer cells. Breast Cancer Res Treat. 2001;69(1):29–38.
   Google Scholar
• Xie W, Zhang J, Zhong P, et al. Expression and potential prognostic value of histone family gene signature in breast cancer. Exp Ther Med. 2019;18(6):4893–4903.
   Google Scholar
• Sun L, Jiang C, Xu C, et al. Down-regulation of long non-coding RNA RP11-708H21. 4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway. Oncotarget. 2017;8(17):27929.
   Google Scholar
• Wu Y, Yang X, Chen Z, et al. m 6 A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1. Mol Cancer. 2019;18(1):1–16.
   Google Scholar
• Qiao Z, Jiang Y, Wang L, et al. Mutations in KIAA1109, CACNA1C, BSN, AKAP13, CELSR2, and HELZ2 are associated with the prognosis in endometrial cancer. Front Genet. 2019;10:909.
   Google Scholar
• Liu P, Weng Y, Sui Z, et al. Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium. Sci Rep. 2016;6:37606.
   Google Scholar
• Dahlman KB, Parker JS, Shamu T, et al. Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screening. PLoS One. 2012;7(4):e34414.
   Google Scholar
• Guo Z, Liu J, Zhang L, et al. KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma. Tumor Biol. 2015;36(2):1251–1259.
   Google Scholar
• Huang S, Qi D, Liang J, et al. The putative tumor suppressor Zc3h12d modulates toll-like receptor signaling in macrophages. Cell Signal. 2012;24(2):569–576.
   Google Scholar
• Anisowicz A, Huang H, Braunschweiger KI, et al. A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer. 2008;8(1):222.
   Google Scholar
• Kondo M, Suzuki H, Ueda R, et al. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene. 1995;10(6):1193–1198.
   Google Scholar
• Langevin SM, Kratzke RA, Kelsey KT. Epigenetics of lung cancer. Transl Res. 2015;165(1):74–90.
   Google Scholar
• Gabory A, Jammes H, The DL. H19 locus: role of an imprinted non‐coding RNA in growth and development. Bioessays. 2010;32(6):473–480.
   Google Scholar
• Miyaso H, Sakurai K, Takase S, et al. The methylation levels of the H19 differentially methylated region in human umbilical cords reflect newborn parameters and changes by maternal environmental factors during early pregnancy. Environ Res. 2017;157:1–8.
   Google Scholar
• Widschwendter M, Jones A, Evans I, et al. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat Rev Clin Oncol. 2018;15(5):292.
   Google Scholar